@article{ajcp2018614,
author={{Payandeh, Mehrdad and Karami, Noorodin and Karami, Afshin and Aeinfar, Mehrnoush and Yami, Amir and Ghorbani, Sakineh and Yousefi, Roshanak},
title={A Good Therapeutic Strategy to Unrecognized HIV Infection in A Patient with Multiple Myeloma Undergoing Peripheral Blood Stem Cell Transplantation - Case Report},
journal={American Journal of Cancer Prevention},
volume={6},
number={1},
pages={17--19},
year={2018},
url={http://pubs.sciepub.com/ajcp/6/1/4},
issn={2328-7314},
abstract={Multiple myeloma is a hematological malignancy associated with increased plasma cell proliferation in the patient's bone marrow. HIV infection is an immunodeficiency disease that is present in some malignancies, such as non-Hodgkin's lymphomas, as an effective factor in the progression of malignancy. Our patient was diagnosed with multiple myeloma and after bone marrow transplantation, it became clear that the patient was HIV positive and also, he had a mild toxoplasmosis infection. After diagnosis, the patient was treated with antiviral drugs and drugs for the treatment of toxoplasma infection. After several months and carrying out the relevant tests, it indicates the control of HIV viral infection, and the patient is still being treated and followed up. Nonetheless, our case features the significance of HIV testing in early malignancy.},
doi={10.12691/ajcp-6-1-4}
publisher={Science and Education Publishing}
}